Northern Trust Corp Genocea Biosciences, Inc. Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.01 - $1.38 $708 - $97,755	-70,837 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$0.95 - $1.99 $13,649 - $28,592	14,368 Added 25.44%	70,837 $82,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.33 $28,861 - $38,647	16,587 Added 41.59%	56,469 $108,000
Q1 2021 May 12, 2021	BUY	$2.35 - $4.01 $470 - $802	200 Added 0.5%	39,882 $108,000
Q4 2020 Feb 11, 2021	BUY	$1.91 - $2.67 $4,524 - $6,325	2,369 Added 6.35%	39,682 $96,000
Q3 2020 Nov 16, 2020	SELL	$1.81 - $5.53 $11,450 - $34,982	-6,326 Reduced 14.5%	37,313 $85,000
Q2 2020 Aug 14, 2020	BUY	$1.66 - $3.06 $26,413 - $48,690	15,912 Added 57.39%	43,639 $100,000
Q3 2019 Nov 13, 2019	BUY	$2.9 - $4.07 $31,931 - $44,814	11,011 Added 65.87%	27,727 $80,000
Q2 2019 Aug 13, 2019	BUY	$3.47 - $6.71 $58,004 - $112,164	16,716 New	16,716 $66,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.